rhil-15
Rhil 15 is a drug used to treat Anaplastic Large Cell Lymphoma, B-Cell, Chronic, and other conditions. Rhil 15 is being actively studied in 2 studies and prior, has been studied in 1.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
National Cancer Institute (NCI) | National Institutes of Health Clinical Center | Kevin Conlon, MD |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Terminated
- Leukemia
- +3 more
- rhIL-15
- Obinutuzumab
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-03-11
Mar 11, 2022N
Completed
- Clear-Cell Renal Carcinoma
- rhIL-15
- Avelumab
- Bethesda, MarylandNational Institutes of Health Clinical Center
2021-09-21
Sep 21, 2021N
Recruiting
- Metastatic Solid Tumors
- Treatment-Refractory Cancers
- rhIL-15
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Active, not recruiting
- Peripheral T-cell Lymphoma NOS
- +3 more
- rhIL-15
- Avelumab
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-02-02
Feb 2, 2022